caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1679523088

Shadan MansoorM.D.

Hematology-OncologyBurleson, TXI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Shadan Mansoor's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 55 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Laboratory Corporation Of America
Clinical Laboratory · Dallas, TX
3293,943
Laboratory Corporation Of America
Clinical Laboratory · Burleson, TX
3053,913
TEXAS HEALTH HUGULEY, INC.2901,981
MURNANE, THOMAS146733
Ammar Hindi
Diagnostic Radiology · Irvine, CA
78360
Hisham Bismar
Critical Care (Intensivists) · Fort Worth, TX
54344
OLTERSDORF, TIMOTHY51163
Kavitha Shashikumar
Infectious Disease · Fort Worth, TX
50207
GORDON, MELISSA49151
Laboratory Corporation Of America
Clinical Laboratory · Fort Worth, TX
48550
Jason Seiden
Pulmonary Disease · Burleson, TX
36235
Ehab Hanna
Internal Medicine · Crowley, TX
33209
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,436
Unique beneficiaries
—
Total services
63,588
Distinct HCPCS
36
Medicare payment
$362K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 613 Hematology-Oncology providers in TX — top quintile (cohort median 2,625).
PRESCRIBING · PART D · 2024
Total Rx claims
824
Beneficiaries
—
Total drug cost
$1.1M
Distinct drugs
26
Brand share
28.5%
Top prescribed drugs
Anastrozole160 claims
Apixaban70 claims
Tamoxifen Citrate55 claims
Ondansetron45 claims
Rivaroxaban40 claims
QUALITY · MIPS · 2024
Final MIPS score
97.8
Quality
3.5
Cost
61.9
Improvement activities
40.0
Promoting interop.
94.0
Payment adjustment
0.96%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$688
Payment records
24
By payment type
Food and Beverage$688